caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1710055264

Randa LoutfiM.D.

Medical OncologyDetroit, MII
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Randa Loutfi's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 23 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
HENRY FORD HEALTH SYSTEM2295,166
HENRY FORD HEALTH SYSTEM35177
Xiaoni Hong
Diagnostic Radiology · Detroit, MI
2788
Haythem Ali
Hematology-Oncology · Detroit, MI
25108
James Mohyi
Cardiology · Wyandotte, MI
2476
Gazala Khan
Hematology-Oncology · Ann Arbor, MI
24215
Ishani Dalal
Diagnostic Radiology · Detroit, MI
2250
Ira Wollner
Medical Oncology · Detroit, MI
20128
Daniel Myers
Diagnostic Radiology · Detroit, MI
2071
Jeffrey Nadig
Diagnostic Radiology · Detroit, MI
1730
Sheela Tejwani
Hematology-Oncology · Detroit, MI
16123
KARVELIS, KASTYTIS1643
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
60
Unique beneficiaries
—
Total services
110
Distinct HCPCS
3
Medicare payment
$7K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 86 Medical Oncology providers in MI — below median (cohort median 430).
PRESCRIBING · PART D · 2024
Total Rx claims
667
Beneficiaries
—
Total drug cost
$914K
Distinct drugs
21
Brand share
22.3%
Top prescribed drugs
Anastrozole209 claims
Letrozole82 claims
Dexamethasone47 claims
Olanzapine42 claims
Apixaban29 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$796
Payment records
10
By payment type
Long term medical supply or device loan$399
Food and Beverage$397